Adma Biologics (ADMA) Gains from Investment Securities (2014 - 2025)
Adma Biologics posted quarterly Gains from Investment Securities of $1.9 million for Q3 2025, up 627.07% year-on-year from $257867.0 in Q3 2024, and up 5.58% on a QoQ basis from $1.8 million in Q2 2025.
Adma Biologics (ADMA) has 12 years of Gains from Investment Securities data on file, last reported at $1.9 million in Q3 2025.
- For the quarter ending Q3 2025, Gains from Investment Securities rose 627.07% year-over-year to $1.9 million; the trailing twelve-month figure through Sep 2025 stood at $1.9 million (up 627.07% YoY), and the FY2024 full-year result was $3.3 million, up 37.11% from the prior year.
- Gains from Investment Securities for Q3 2025 stood at $1.9 million, up from $1.8 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.8 million in Q2 2024 and bottomed at $1000.0 in Q4 2023.
- The 5-year median for Gains from Investment Securities is $1.7 million (2021), against an average of $1.3 million.
- The widest annual swing landed in 2023, when Gains from Investment Securities plunged 88.53%; it then surged 627.07% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $8493.0 in 2021, then rose by 2.66% to $8719.0 in 2022, then slumped by 88.53% to $1000.0 in 2023, then surged by 25686.7% to $257867.0 in 2024, then soared by 627.07% to $1.9 million in 2025.
- The last three Gains from Investment Securities figures came in at $1.9 million (Q3 2025), $1.8 million (Q2 2025), and $1.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Adma Biologics | 1.90 Bn | 1.81 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.78 Mn |
| Jun 30, 2025 | 1.78 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Sep 30, 2024 | 257,867.00 |
| Sep 30, 2024 | 257,867.00 |
| Jun 30, 2024 | 2.78 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1.73 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 8,719.00 |
| Dec 31, 2022 | 8,719.00 |
| Sep 30, 2022 | 1.19 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.19 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 8,493.00 |
| Dec 31, 2021 | 8,493.00 |
| Sep 30, 2021 | 1.76 Mn |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 1.66 Mn |
| Jun 30, 2021 | 1.66 Mn |
| Mar 31, 2021 | 1.44 Mn |
| Mar 31, 2021 | 1.44 Mn |
| Dec 31, 2020 | 8,220.00 |
| Dec 31, 2020 | 8,220.00 |
| Jun 30, 2020 | 1.23 Mn |
| Jun 30, 2020 | 1.23 Mn |
| Mar 31, 2020 | 1.16 Mn |
| Mar 31, 2020 | 1.16 Mn |
| Dec 31, 2019 | -8.20 Mn |
| Dec 31, 2019 | -8.20 Mn |
| Jun 30, 2019 | 113,667.00 |
| Jun 30, 2019 | 113,667.00 |
| Mar 31, 2019 | 5.60 Mn |
| Mar 31, 2019 | 5.60 Mn |
| Dec 31, 2018 | 4.34 Mn |
| Dec 31, 2018 | 4.34 Mn |
| Mar 31, 2018 | 4.13 Mn |
| Mar 31, 2018 | 4.13 Mn |
| Dec 31, 2017 | 3.28 Mn |
| Dec 31, 2017 | 3.28 Mn |
| Sep 30, 2017 | 87,324.00 |
| Sep 30, 2017 | 87,324.00 |
| Jun 30, 2017 | 3.32 Mn |
| Jun 30, 2017 | 3.32 Mn |
| Mar 31, 2017 | 19,814.00 |
| Mar 31, 2017 | 19,814.00 |
| Dec 31, 2016 | 1.54 Mn |
| Dec 31, 2016 | 1.54 Mn |
| Dec 31, 2015 | 1.46 Mn |
| Dec 31, 2015 | 1.46 Mn |
| Dec 31, 2014 | 1.05 Mn |
| Dec 31, 2014 | 1.05 Mn |